Oct 24 (Reuters) - Bayer AG BAYGn.DE :
* BAYER AG - RECEIVES APPROVAL FOR HEMOPHILIA A TREATMENT JIVI
* BAYER - HEALTH CANADA ALSO APPROVED JIVI FOR CONTROL AND PREVENTION OF EPISODIC BLEEDING, AND PERI-OPERATIVE MANAGEMENT OF BLEEDING
* BAYER - RECOMMENDED INITIAL PROPHYLACTIC REGIMEN FOR JIVI IS TWICE WEEKLY